Compound C induces autophagy and apoptosis in parental and hydroquinone-selected malignant leukemia cells through the ROS/p38 MAPK/AMPK/TET2/FOXP3 axis

• Published in: Cell biology and toxicology Vol. 36; no. 4; pp. 315 - 331
• Main Authors: Chiou, Jing-Ting, Huang, Chia-Hui, Lee, Yuan-Chin, Wang, Liang-Jun, Shi, Yi-Jun, Chen, Ying-Jung, Chang, Long-Sen
• Format: Journal Article
• Language: English
• Published: Dordrecht Springer Netherlands 01.08.2020; Springer Nature B.V
• Subjects: Acute myeloid leukemia; Apoptosis; Autophagy; Benzene; Biochemistry; Biomedical and Life Sciences; Cell Biology; Cell survival; Cytotoxicity; Demethylation; Exposure; Foxp3 protein; Hydrocarbons; Hydroquinone; Leukemia; Life Sciences; MAP kinase; Myeloid leukemia; Original Article; Phagocytosis; Pharmacology/Toxicology; Pretreatment; Rapamycin; Restoration; TOR protein; Toxicity; Hydroquinone; TET2; AMPK; FOXP3; Leukemia
• ISSN: 0742-2091; 1573-6822; 1573-6822
• DOI: 10.1007/s10565-019-09495-3

Hydroquinone (HQ), a major metabolic product of benzene, causes acute myeloid leukemia (AML) elicited by benzene exposure . Past studies found that continuous exposure of human AML U937 cells to HQ selectively produces malignant U937/HQ cells in which FOXP3 upregulation modulates malignant progression. Other studies revealed that AMPK promotes TET2 activity on DNA demethylation and that TET2 activity is crucial for upregulating FOXP3 expression. This study was conducted to elucidate whether compound C, an AMPK inhibitor, blocked the AMPK–TET2–FOXP3 axis in AML and in HQ-selected malignant cells. We found higher levels of AMPKα, TET2, and FOXP3 expression in U937/HQ cells compared to U937 cells. Treatment of parental Original Article and HQ-selected malignant U937 cells with compound C induced ROS-mediated p38 MAPK activation, leading to a suppression of AMPKα, TET2, and FOXP3 expression. Moreover, compound C induced apoptosis and mTOR-independent autophagy. The suppression of the autophagic flux inhibited the apoptosis of compound C-treated U937 and U937/HQ cells, whereas co-treatment with rapamycin, a mTOR inhibitor, sensitized the two cell lines to compound C cytotoxicity. Overexpression of AMPKα1 or pretreatment with autophagic inhibitors abrogated compound C-induced autophagy and suppression of TET2 and FOXP3 expression. Restoration of AMPKα1 or FOXP3 expression increased cell survival after treatment with compound C. In conclusion, our results show that compound C suppresses AMPK/TET2 axis-mediated FOXP3 expression and induces autophagy-dependent apoptosis in parental and HQ-selected malignant U937 cells, suggesting that the AMPK/TET2/FOXP3 axis is a promising target for improving AML therapy and attenuating benzene exposure-induced AML progression.